190 results
8-K
EX-10.2
AVTX
Avalo Therapeutics Inc
28 Mar 24
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
6:08am
supplemented; provided, however, that each Purchaser shall be responsible for the delivery of the Prospectus to the Persons to whom such Purchaser sells … , not to exceed $50,000 in the aggregate, per registration. In addition, the Company shall be responsible for all of its internal expenses incurred
8-K
EX-2.1
AVTX
Avalo Therapeutics Inc
28 Mar 24
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
6:08am
the Closing, in making payments in cash or stock under this Agreement, and Parent shall (x) not be responsible for the calculations, allocations
8-K
EX-10.1
2l55wv95
28 Mar 24
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
6:08am
8-K
EX-2.1
phnsu006d4eu8yhv0
12 Sep 23
Avalo Enters into Agreement to Divest AVTX-800 Series
7:10am
8-K
EX-4.1
f2o3vjdembq6kz95d
2 Jun 23
Entry into a Material Definitive Agreement
7:05am
8-K
EX-1.1
ysar oakt883j42im
4 May 23
Entry into a Material Definitive Agreement
4:56pm